Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00385541 · ClinicalTrials.gov registry record · Phase 4
Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA)
A Phase 4 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00385541: Completed Phase 4 study, sponsored by Columbia University.
NCT00385541 is a Phase 4 study that has completed, run by Columbia University. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00385541, a Phase 4 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
Both morphine and hydromorphone are pain medications commonly used after surgery. It is thought at the institution that hydromorphone causes less side effects but this has not been studied. The study proposes to treat the patients with either morphine or hydromorphone and determine how much nausea, vomiting, and itching they have with each drug
Primary Outcome
Nausea scale range: (0 = none, 10 = the worst), ordinal.
Interventions
- DRUG Hydromorphone PCA
- DRUG Morphine PCA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2003-11 |
| Est. Completion | 2007-10 |
| Phase | Phase 4 |
What the finished NCT00385541 record still lists
NCT00385541 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Hydromorphone PCA is the first listed.
NCT00385541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00385541 about?
NCT00385541 is a clinical study titled "Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA)". Both morphine and hydromorphone are pain medications commonly used after surgery. It is thought at the institution that hydromorphone causes less side effects but this has not been studied. The study proposes to treat the patients with either morphine or hydromorphone and determine how much nausea, ...
What is the current status of trial NCT00385541?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2003-11. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00385541?
The interventions under investigation include: Hydromorphone PCA (DRUG), Morphine PCA (DRUG).
Who is sponsoring clinical trial NCT00385541?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00385541's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia